European practice guidelines: thromboembolism prophylaxis and regional anesthesia.
Tryba
M
M
Department of Anesthesia, Intensive Care Medicine and Pain Therapy, City Hospital Kassel, University Teaching Hospital, Germany.
D000765:Anesthesia, Conduction / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D005060:Europe; D006470:Hemorrhage / Q000209:etiology; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D013118:Spinal Cord Diseases / Q000209:etiology; D013927:Thrombosis / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin